Soricimed Biopharma Inc
1 clinical trials · Sponsor
◉ Watch Soricimed Biopharma Inc
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel (NCT01578564) | Soricimed Biopharma Inc | 2012-07-01 |
Track Soricimed Biopharma Inc automatically
Every clearance here is in the API, with alerts when new ones post.